Trial Profile
A Phase IIb trial of Lunacalcipol (CTA018).
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 13 Feb 2017
Price :
$35
*
At a glance
- Drugs Lunacalcipol (Primary)
- Indications Secondary hyperparathyroidism
- Focus Therapeutic Use
- 13 Feb 2017 New trial record